SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
慧19960418
Lv4
712 积分
2023-09-07 加入
最近求助
最近应助
互助留言
Cancer incidence and mortality in China, 2022
3天前
已完结
Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
10天前
已完结
Pucotenlimab: First Approval
11天前
已完结
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
12天前
已完结
Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis
12天前
已完结
Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations
12天前
已完结
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
18天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
19天前
已完结
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
24天前
已完结
Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
24天前
已完结
没有进行任何应助
以获取【积分已退回】
25天前
文献错误【积分已退回】
1个月前
已找到【积分已退回】
1个月前
已找到【积分已退回】
1个月前
已找到【积分已退回】
2个月前
已找到【积分已退回】
2个月前
已找到【积分已退回】
2个月前
已找到【积分已退回】
2个月前
已找到【积分已退回】
2个月前
已找到【积分已退回】
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论